Compare Hims and Hers Health Inc (HIMS) vs Wix.Com Ltd (WIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hims and Hers Health Inc vs Wix.Com Ltd — how do they compare? Hims and Hers Health Inc trades at $30.92 (market cap $6.55B), while Wix.Com Ltd trades at $76.56 (market cap $3.11B). The key difference: Hims and Hers Health Inc is far larger — about 2.1× Wix.Com Ltd's market cap, and Wix.Com Ltd is more actively traded (809,286 versus 14,842,814). Which is the better fit depends on your goals — on Pluang, investors hold Hims and Hers Health Inc for 21 Days and Wix.Com Ltd for 62 Days on average.
| HIMS | WIX | |
|---|---|---|
Market Cap | $6.55B | $3.11B |
Volume | 14,842,814 | 809,286 |
Sector | Health | Technology |
52-Week High | $62.76 | $145.54 |
52-Week Low | $14.52 | $40.43 |
Typical Hold Time | 21 Days | 62 Days |
Enterprise Value | $7.25B | $4.19B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HIMS stock trades at $28.06, down 5.01% on the day, reflecting bearish technical signals and negative earnings surprises in recent quarters. The company reported strong revenue growth to $2.35 billion in 2025 but swung to a net loss of -$142 million in 2026, with profitability metrics deteriorating. Multiple securities class action lawsuits filed in October 2026 create significant legal overhangs, while analyst consensus remains cautiously optimistic with a $32.17 price target despite mixed fundamental performance.
The outlook is clouded by legal risks and profitability challenges, though the 15% upside to consensus target suggests potential recovery if execution improves. Key risks include ongoing litigation outcomes and the company's ability to return to sustainable profitability amid competitive pressures in the telehealth sector.
Wix.com (WIX) trades at $74.13, up 1.59% with mixed technical signals showing neutral overall but bullish moving averages. The company reported Q2 2026 EPS of $1.39, beating expectations, but faces negative net income margin of -8.19% despite strong revenue growth to $1.99 billion in 2025. Multiple class action lawsuits filed in September 2026 create near-term legal overhang.
Analyst consensus remains positive with 26 buy ratings and $77 price target, but investors face risks from negative cash flow trends, legal challenges, and inconsistent profitability. The stock offers growth potential if Wix can maintain revenue momentum while improving cost controls, but legal proceedings could pressure shares near-term.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →About Wix.Com Ltd
Wix.com Ltd is a cloud-based development platform provider for millions of registered users worldwide. The company is engaged in web development and management that provides an easy-to-use powerful cloud-based platform of products through a freemium model. Its core products consist of three web editors: the Wix Editor, intended for users with basic technological skills, Wix ADI, intended for novice users and Corvid, intended for more tech-savvy users. The company's web development technology is built based on HTML5 and offers HTML5 compatible capabilities, web design and layout tools, domain hosting, and other marketing and workflow management applications and services. The geographic segments include North America, Europe, Latin America, Asia and others.
Read more on WIX →
